Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data
Immune checkpoint inhibitors (ICIs) have improved the management of patients with intermediate- and advanced-stage HCC, even making some of them potential candidates for liver transplantation. However, acute rejection has been observed after ICI therapy, challenging its safety in transplant settings...
Main Authors: | Charles-Henri Wassmer, Sofia El Hajji, Xenofon Papazarkadas, Philippe Compagnon, Parissa Tabrizian, Stéphanie Lacotte, Christian Toso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/18/4574 |
Similar Items
-
Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review
by: Zurabi Lominadze, et al.
Published: (2023-01-01) -
Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology
by: Saad Alghamdi, et al.
Published: (2023-10-01) -
Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
by: Jingyu Jiang, et al.
Published: (2023-02-01) -
Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View
by: Maen Abdelrahim, et al.
Published: (2022-03-01) -
Risk Factors of Rejection in Renal Transplant Recipients: A Narrative Review
by: Hani Oweira, et al.
Published: (2022-03-01)